DISSEMINATED HISTOPLASMOSIS AFTER VEDOLIZUMAB USE FOR ULCERATIVE COLITIS

被引：0
|
作者：
Murskyj, Ivanna O. [1 ]
Joy, Joydip [4 ]
Henkin, David R. [2 ]
Garza, Nina [3 ]
Shah, Vinay [3 ]
机构：
[1] Henry Ford Hosp, Internal Med, Troy, MI USA
[2] Henry Ford Hosp, Internal Med, Detroit, MI 48202 USA
[3] Henry Ford Hosp, Dept Internal Med, Detroit, MI 48202 USA
[4] Wayne State Univ, Detroit, MI USA
来源：
JOURNAL OF GENERAL INTERNAL MEDICINE | 2020年 / 35卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：S447 / S447
页数：1
相关论文
共 50 条
  • [1] Vedolizumab for the treatment of ulcerative colitis
    Stallmach, Andreas
    Schmidt, Carsten
    Teich, Niels
    [J]. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 10 (02) : 165 - 175
  • [2] Subcutaneous vedolizumab for ulcerative colitis
    Brierley, Rob
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2019, 4 (01): : 16 - 16
  • [3] Vedolizumab for the treatment of ulcerative colitis
    Shahidi, Neal
    Bressler, Brian
    Panaccione, Remo
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2016, 16 (01) : 129 - 135
  • [4] Vedolizumab for the treatment of ulcerative colitis
    Rietdijk, Svend T.
    D'Haens, Geert R.
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2014, 7 (04) : 423 - 430
  • [5] Subcutaneous vedolizumab for ulcerative colitis
    Baker, Holly
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2019, 4 (11): : 826 - 826
  • [6] Use of Tofacitinib for the Treatment of Arthritis Associated With Vedolizumab in Ulcerative Colitis
    Rubin, David T.
    Cleveland, Noa Krugliak
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S1098 - S1099
  • [7] Vedolizumab vs adalimumab for ulcerative colitis
    Feetham, Laura
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2019, 4 (05): : 337 - 337
  • [8] Combination of vedolizumab and immunomodulators in ulcerative colitis
    Pinton, P.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (12) : 3556 - 3556
  • [9] Review of vedolizumab for the treatment of ulcerative colitis
    Michelle SY Lau
    Her Hsin Tsai
    [J]. World Journal of Gastrointestinal Pharmacology and Therapeutics, 2016, (01) : 107 - 111
  • [10] The safety of vedolizumab for the treatment of ulcerative colitis
    Novak, Gregor
    Hindryckx, Pieter
    Khanna, Reena
    Jairath, Vipul
    Feagan, Brian G.
    [J]. EXPERT OPINION ON DRUG SAFETY, 2017, 16 (04) : 501 - 507
12345